Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 2003;58:294-298; doi:10.1136/thorax.58.4.294
Copyright © 2003 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 2003;58:294-298
© 2003 BMJ Publishing Group & British Thoracic Society

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD

W A Biernacki, S A Kharitonov, P J Barnes

Department of Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Royal Brompton Hospital, London SW3 6LY, UK

Correspondence to:
Correspondence to:
Professor P J Barnes, Department of Thoracic Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK;
p.j.barnes{at}ic.ac.uk

Background: Exacerbations are an important feature of chronic obstructive pulmonary disease (COPD), accounting for a large proportion of health care costs. They are associated with increased airway inflammation and oxidative stress.

Methods: Concentrations of leukotriene B4 (LTB4), a marker of inflammation, and 8-isoprostane, a marker of oxidative stress, were measured in the exhaled breath condensate of 21 patients (11 M) with COPD during an exacerbation and 2 weeks after treatment with antibiotics. In 12 patients who had no further exacerbations these markers were also measured after 2 months.

Results: LTB4 concentrations were raised during the COPD exacerbation (mean (SE) 15.8 (1.1) pg/ml and fell after treatment with antibiotics to 9.9 (0.9) pg/ml (p<0.0001). In 12 patients the level of LTB4 fell further from 10.6 (1.1) pg/ml to 8.5 (0.8) pg/ml (p<0.005) after 2 months. In 12 normal age matched subjects the LTB4 levels were 7.7 (0.5) pg/ml. Concentrations of 8-isoprostane were also increased during the exacerbation (13.0 (0.9) pg/ml) and fell after antibiotic treatment to 9.0 (0.6) pg/ml (p<0.0001). In 12 patients there was a further fall from 9.3 (0.7) pg/ml to 6.0 (0.7) pg/ml (p<0.001) after 2 months compared with normal subjects (6.2 (0.4) pg/ml).

Conclusions: Non-invasive markers of inflammation and oxidative stress are increased during an infective exacerbation of COPD and only slowly recover after treatment with antibiotics.

Keywords: chronic obstructive pulmonary disease; exacerbation; inflammation; oxidative stress


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2003 58: 283. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Corhay, J.-L., Henket, M., Nguyen, D., Duysinx, B., Sele, J., Louis, R. (2009). Leukotriene B4 Contributes to Exhaled Breath Condensate and Sputum Neutrophil Chemotaxis in COPD. Chest 136: 1047-1054 [Abstract] [Full Text]  
  • Cruz, M.-J., Sanchez-Vidaurre, S., Romero, P.-V., Morell, F., Munoz, X. (2009). Impact Of Age on pH, 8-Isoprostane, and Nitrogen Oxides in Exhaled Breath Condensate. Chest 135: 462-467 [Abstract] [Full Text]  
  • Flamand, N., Luo, M., Peters-Golden, M., Brock, T. G. (2009). Phosphorylation of Serine 271 on 5-Lipoxygenase and Its Role in Nuclear Export. J. Biol. Chem. 284: 306-313 [Abstract] [Full Text]  
  • Barnes, P. J. (2008). Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities. Proc Am Thorac Soc 5: 857-864 [Abstract] [Full Text]  
  • Do, R., Bartlett, K. H., Dimich-Ward, H., Chu, W., Kennedy, S. M. (2008). Biomarkers of Airway Acidity and Oxidative Stress in Exhaled Breath Condensate from Grain Workers. Am. J. Respir. Crit. Care Med. 178: 1048-1054 [Abstract] [Full Text]  
  • Borrill, Z. L., Roy, K., Singh, D. (2008). Exhaled breath condensate biomarkers in COPD. Eur Respir J 32: 472-486 [Abstract] [Full Text]  
  • Sapey, E, Bayley, D, Ahmad, A, Newbold, P, Snell, N, Stockley, R A (2008). Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 63: 493-499 [Abstract] [Full Text]  
  • Bayley, D. L., Abusriwil, H., Ahmad, A., Stockley, R. A. (2008). Validation of assays for inflammatory mediators in exhaled breath condensate. Eur Respir J 31: 943-948 [Abstract] [Full Text]  
  • Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., Jones, P. W., Mahler, D. A., Make, B., Miravitlles, M., Page, C. P., Palange, P., Parr, D., Pistolesi, M., Rennard, S. I., Rutten-van Molken, M. P., Stockley, R., Sullivan, S. D., Wedzicha, J. A., Wouters, E. F., on behalf of the American Thoracic Society/Europea, (2008). Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31: 416-469 [Abstract] [Full Text]  
  • Seto, V., Hirota, C., Hirota, S., Janssen, L. J. (2008). E-Ring Isoprostanes Stimulate a Cl Conductance in Airway Epithelium via Prostaglandin E2-Selective Prostanoid Receptors. Am. J. Respir. Cell Mol. Bio. 38: 88-94 [Abstract] [Full Text]  
  • Wedzicha, J. A., Hurst, J. R. (2007). Structural and Functional Co-conspirators in Chronic Obstructive Pulmonary Disease Exacerbations. Proc Am Thorac Soc 4: 602-605 [Abstract] [Full Text]  
  • Paredes, C., Tazzeo, T., Janssen, L. J. (2007). E-Ring Isoprostane Augments Cholinergic Neurotransmission in Bovine Trachealis via FP Prostanoid Receptors. Am. J. Respir. Cell Mol. Bio. 37: 739-747 [Abstract] [Full Text]  
  • Montuschi, P. (2007). Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 1: 5-23 [Abstract]  
  • Yoshida, T., Tuder, R. M. (2007). Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease. Physiol. Rev. 87: 1047-1082 [Abstract] [Full Text]  
  • Lehtonen, H., Oksa, P., Lehtimaki, L., Sepponen, A., Nieminen, R., Kankaanranta, H., Saarelainen, S., Jarvenpaa, R., Uitti, J., Moilanen, E. (2007). Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 62: 602-607 [Abstract] [Full Text]  
  • Celli, B. R., Barnes, P. J. (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238 [Abstract] [Full Text]  
  • Corhay, J.-L., Hemelaers, L., Henket, M., Sele, J., Louis, R. (2007). Granulocyte Chemotactic Activity in Exhaled Breath Condensate of Healthy Subjects and Patients With COPD. Chest 131: 1672-1677 [Abstract] [Full Text]  
  • Kinnula, V. L., Ilumets, H., Myllarniemi, M., Sovijarvi, A., Rytila, P. (2007). 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 29: 51-55 [Abstract] [Full Text]  
  • Gaber, F., Acevedo, F., Delin, I., Sundblad, B-M., Palmberg, L., Larsson, K., Kumlin, M., Dahlen, S-E. (2006). Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J 28: 1229-1235 [Abstract] [Full Text]  
  • Liu, C., Tazzeo, T., Janssen, L. J. (2006). Isoprostane-induced airway hyperresponsiveness is dependent on internal Ca2+ handling and Rho/ROCK signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1177-L1184 [Abstract] [Full Text]  
  • Kharitonov, S. A., Barnes, P. J. (2006). Exhaled biomarkers.. Chest 130: 1541-1546 [Abstract] [Full Text]  
  • Goldbart, A. D., Krishna, J., Li, R. C., Serpero, L. D., Gozal, D. (2006). Inflammatory Mediators in Exhaled Breath Condensate of Children With Obstructive Sleep Apnea Syndrome.. Chest 130: 143-148 [Abstract] [Full Text]  
  • Barnes, P. J., Chowdhury, B., Kharitonov, S. A., Magnussen, H., Page, C. P., Postma, D., Saetta, M. (2006). Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 174: 6-14 [Abstract] [Full Text]  
  • Marian, E., Baraldo, S., Visentin, A., Papi, A., Saetta, M., Fabbri, L. M., Maestrelli, P. (2006). Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD. Chest 129: 1523-1530 [Abstract] [Full Text]  
  • Papi, A., Luppi, F., Franco, F., Fabbri, L. M. (2006). Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 3: 245-251 [Abstract] [Full Text]  
  • Ochs-Balcom, H. M., Grant, B. J. B., Muti, P., Sempos, C. T., Freudenheim, J. L., Browne, R. W., Trevisan, M., Iacoviello, L., Cassano, P. A., Schunemann, H. J. (2005). Oxidative Stress and Pulmonary Function in the General Population. Am J Epidemiol 162: 1137-1145 [Abstract] [Full Text]  
  • Adcock, I. M., Ito, K. (2005). Glucocorticoid Pathways in Chronic Obstructive Pulmonary Disease Therapy. Proc Am Thorac Soc 2: 313-319 [Abstract] [Full Text]  
  • Mallia, P., Johnston, S. L. (2005). Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations. Proc Am Thorac Soc 2: 361-366 [Abstract] [Full Text]  
  • Horvath, I., Hunt, J., Barnes, P. J., On behalf of the ATS/ERS Task Force on Exhaled Bre, (2005). Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26: 523-548 [Abstract] [Full Text]  
  • Brock, T. G., Lee, Y.-J., Maydanski, E., Marburger, T. L., Luo, M., Paine, R. III, Peters-Golden, M. (2005). Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L224-L232 [Abstract] [Full Text]  
  • Barnes, P. J., Stockley, R. A. (2005). COPD: current therapeutic interventions and future approaches. Eur Respir J 25: 1084-1106 [Abstract] [Full Text]  
  • Tsoumakidou, M., Tzanakis, N., Chrysofakis, G., Siafakas, N. M. (2005). Nitrosative Stress, Heme Oxygenase-1 Expression and Airway Inflammation During Severe Exacerbations of COPD. Chest 127: 1911-1918 [Abstract] [Full Text]  
  • Baydur, A. (2005). Not All That Comes Out Is Hot Air. Chest 127: 1482-1485 [Full Text]  
  • Barnes, P. J., Adcock, I. M., Ito, K. (2005). Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25: 552-563 [Abstract] [Full Text]  
  • Harrison, C M, Andersen, C C (2005). Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?. Arch. Dis. Child. Fetal Neonatal Ed. 90: F6-F10 [Abstract] [Full Text]  
  • Barnes, P. J. (2004). Mediators of Chronic Obstructive Pulmonary Disease. Pharmacol. Rev. 56: 515-548 [Abstract] [Full Text]  
  • Kharitonov, S. A., Barnes, P. J. (2004). Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 1: 191-199 [Abstract] [Full Text]  
  • Moloney, E. D., Mumby, S. E., Gajdocsi, R., Cranshaw, J. H., Kharitonov, S. A., Quinlan, G. J., Griffiths, M. J. (2004). Exhaled Breath Condensate Detects Markers of Pulmonary Inflammation after Cardiothoracic Surgery. Am. J. Respir. Crit. Care Med. 169: 64-69 [Abstract] [Full Text]  
  • Barnes, P.J., Shapiro, S.D., Pauwels, R.A. (2003). Chronic obstructive pulmonary disease: molecular and cellularmechanisms. Eur Respir J 22: 672-688 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs